Azafaros
0 followers
Azafaros is developing new treatment options to help patients with rare metabolic disorders. Azafaros was founded in 2018 by a team of experienced industry professionals and scientists aspiring to address rare genetic metabolic disorders through a pipeline of oral small molecules with disease-modify... Read more
Org chart
Stefano Portolano
CEO & Executive Board Member
Stefano Portolano
Collapse
Silvia Ragno
COO
Kyle Landskroner
Head of Preclinical Drug Development
Cecile Paquet Luzy
Head of Clinical Sciences
Gisela Linthorst
Head Of Patient Engagement And Advocacy
Anke Arnold-Tugulu
Head of Regulatory Affairs
Laura López de Frutos
Regional Medical Director Europe
Dr. Kyung-Jae Na
Head of CMC
